Kraig Biocraft Laboratories, Inc. (KBLB) › Cash & EquivalentsKraig Biocraft Laboratories, Inc. (KBLB) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $92.2K2011: $195.4K2012: $53.8K2013: $295.4K2014: $495.0K2015: $238.2K2016: $298.9K2017: $18.1K2018: $13.7K2022: $3.86M2023: $2.55M2024: $673.3K2025: $1.79M$1.79M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.79M+165.9%2024$673.3K-73.6%2023$2.55M-33.9%2022$3.86M—2018$13.7K-24.5%2017$18.1K-93.9%2016$298.9K+25.5%2015$238.2K-51.9%2014$495.0K+67.6%2013$295.4K+449.2%2012$53.8K-72.5%2011$195.4K+111.8%2010$92.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share